Precipio (PRPO): Advanced Blood Diagnostics

Precipio (PRPO): Advanced Blood Diagnostics

From MicroCapClub by MicroCapClub

April 27, 2026 · 52 min

About this episode

David Barbato and Sean Westropp discuss Precipio's innovative approach to blood diagnostics with CEO Ilan Danieli.

In this Business Breakdown, David Barbato and Sean Westropp from Deep Sail Capital sit down with Precipio’s (PRPO) CEO Ilan Danieli. The company was originally profiled by Sean Westropp, aka "Deepsailcapital" on June 26, 2025, at $11.20 USD per share. This discussion took place live on April 22nd, 2026, on the MicroCapClub Community. Join MicroCapClub and unlock the ability to listen and participate live in these discussions - https://microcapclub.com/#join Ilan Danieli is co-founder and CEO of Precipio, a New Haven-based diagnostics company he started in 2011. Precipio runs a pathology services lab focused on blood-related cancers alongside a products division that develops molecular diagnostic assays, including a four-hour AML panel that replaces the industry-standard 10-to-15-day wait for genetic results. In this Business Breakdown, Ilan walks through Precipio's dual model, how the clinical lab funds and accelerates product R&D (the recent BCR-ABL assay was developed for under $100,000, versus a $5–10M industry norm), and the company's 2025 inflection to profitability on 30% revenue growth. Sean Westropp, CIO of Deep Sail Capital, joins David for the Q&A…

People in this episode

Host: David Barbato

Guests: Sean Westropp, Ilan Danieli

Topics covered

  • blood diagnostics
  • business model
  • molecular diagnostics
  • revenue growth
  • clinical lab
  • product development

Keywords

  • Precipio
  • blood-related cancers
  • diagnostics
  • BCR-ABL assay
  • revenue mix
  • product gross margins
  • clinical lab funding

Mentioned in this episode

Organizations: Deep Sail Capital, Precipio

Places: New Haven

More episodes of MicroCapClub

Explore listener stats, chart rankings, contacts and more on the MicroCapClub podcast page.